Vynleads, Inc.

Market Cap $4.65M
Debt $540.25K
Cash $0.00
EV $5.19M
FCF $NaN

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$257.93K
EBIT	-$230.31K
ROA	-2K%
Equity	-$853.97K
Growth Stability	1
PE	-18.04
PB	-5.45
Price/Cash	0
Debt/Equity	-0.63
Sales CAGR	-23%
Equity CAGR	-0%
Earnings Growth YoY	-6%
Earnings Growth QoQ	1%
Sales CAGR 5Y	-30%
Earnings CAGR 3Y	-5%

Sales CAGR 3Y	-5%
Market Cap	$4.65M
Assets	$14.78K
Total Debt	$540.25K
Cash	$0.00
Shares Outstanding	11.63M
EV	5.19M
Working Capital	-853.97K
Current Ratio	0.02
Gross Profit	-$22.71K
Shares Growth 3y	0%
Equity Growth QoQ	1%
Equity Growth YoY	15%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Vynleads Inc is a provider of health and wellness information for people who are pre-diabetes or who have type 2 diabetes. Its core product is Done With Diabetes (DWD), which helps families manage, control, and prevent type 2 diabetes by providing them education, information, tools, and resources on an all-inclusive science-based platform. Its other product is Lifestyle Blueprint, a digital guide that provides dietary recommendations for a very low-calorie eight-week diet together with information focusing on what, how, and how much a person eats, nutritional information, and how a person's body does and does not use food to enable its customers to continue a more successful lifestyle.

SEC Filings

Direct access to Vynleads, Inc. (VYND) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Vynleads, Inc. compare to its competitors?

Not enough data to generate a comparison chart between Vynleads, Inc. and its competitors. Please check back later.

Peter Lynch's Chart

This chart shows the current pricing of Vynleads, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Vynleads, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Vynleads, Inc..

Years

Calculation mode

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
DCF		$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Value	$0

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	-29%	-76%	-787%	-56K%	-558K%	-	-
ROA	-	-266%	-980%	-1K%	-1K%	-648%	-2K%
ROE	-	224%	108%	55%	43%	34%	-

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	-	-	-	-	-	-
Debt over Equity	-	-0.55	-0.35	-0.48	-0.56	-0.63	-0.63
Growth Stability	-	-	-	-	-	-	1

Neutral Debt/FCF ratio (-)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Good Debt/Equity ratio (-0.63)

The company is not overleveraged and has a good balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	-78%	-88%	-99%	-90%	-	-30%
Earnings YoY growth	-	-42%	25%	-28%	1%	-4%	-
Equity YoY growth	-	-367%	159%	40%	29%	21%	-
FCF YoY growth	-	-	-	-	-	-	-